Educating families on real time continuous glucose monitoring: the DirecNet navigator pilot study experience
- PMID: 19244568
- PMCID: PMC3756565
- DOI: 10.1177/0145721708325157
Educating families on real time continuous glucose monitoring: the DirecNet navigator pilot study experience
Abstract
Purpose: The purpose of this article is to describe the process of educating families and children with type 1 diabetes on real time continuous glucose monitoring (RT-CGM) and to note the similarities and differences of training patients using continuous subcutaneous insulin infusion (CSII) versus multiple daily injections (MDI).
Methods: A total of 30 CSII participants and 27 MDI participants were educated using the Navigator RT-CGM in a clinical trial. Time spent with families for visits and calls was tracked and compared between patient groups. The Diabetes Research in Children Network (DirecNet) educators were surveyed to assess the most crucial, time intensive, and difficult educational concepts related to CGM.
Results: Of the 27 MDI families, an average of 9.6 hours was spent on protocol-prescribed visits and calls (not measured in CSII) and 2 hours on participant-initiated contacts over 3 months. MDI families required an average of 5.4 more phone contacts over 3 months than CSII families. According to the DirecNet educators, lag time and calibrations were the most crucial teaching concepts for successful RT-CGM use. The most time was spent on teaching technical aspects, troubleshooting, and insulin dosing. The most unanticipated difficulties were skin problems including irritation and the sensor not adhering well.
Conclusion: Educators who teach RT-CGM should emphasize lag time and calibration techniques, technical device training, and sensor insertion. Follow-up focus should include insulin dosing adjustments and skin issues. The time and effort required to introduce RT-CGM provided an opportunity for the diabetes educators to reemphasize good diabetes care practices and promote self-awareness and autonomy to patients and families.
Similar articles
-
Prolonged use of continuous glucose monitors in children with type 1 diabetes on continuous subcutaneous insulin infusion or intensive multiple-daily injection therapy.Pediatr Diabetes. 2009 Apr;10(2):91-6. doi: 10.1111/j.1399-5448.2008.00476.x. Epub 2008 Oct 20. Pediatr Diabetes. 2009. PMID: 19175899
-
Real-time continuous glucose monitoring or continuous subcutaneous insulin infusion, what goes first?: results of a pilot study.Diabetes Technol Ther. 2013 Jul;15(7):596-600. doi: 10.1089/dia.2013.0033. Epub 2013 Apr 30. Diabetes Technol Ther. 2013. PMID: 23631604 Clinical Trial.
-
Effect of initiating use of an insulin pump in adults with type 1 diabetes using multiple daily insulin injections and continuous glucose monitoring (DIAMOND): a multicentre, randomised controlled trial.Lancet Diabetes Endocrinol. 2017 Sep;5(9):700-708. doi: 10.1016/S2213-8587(17)30217-6. Epub 2017 Jul 12. Lancet Diabetes Endocrinol. 2017. PMID: 28711468 Clinical Trial.
-
Diabetes technology and treatments in the paediatric age group.Int J Clin Pract Suppl. 2011 Feb;(170):76-82. doi: 10.1111/j.1742-1241.2010.02582.x. Int J Clin Pract Suppl. 2011. PMID: 21323816 Review.
-
Continuous Glucose Monitoring: A Review of Recent Studies Demonstrating Improved Glycemic Outcomes.Diabetes Technol Ther. 2017 Jun;19(S3):S25-S37. doi: 10.1089/dia.2017.0035. Diabetes Technol Ther. 2017. PMID: 28585879 Free PMC article. Review.
Cited by
-
Continuous glucose monitoring in children and adolescents.Curr Diab Rep. 2012 Oct;12(5):510-6. doi: 10.1007/s11892-012-0303-6. Curr Diab Rep. 2012. PMID: 22791108 Review.
-
Influences on Technology Use and Efficacy in Type 1 Diabetes.J Diabetes Sci Technol. 2016 May 3;10(3):647-55. doi: 10.1177/1932296816639315. Print 2016 May. J Diabetes Sci Technol. 2016. PMID: 27022096 Free PMC article. Review.
-
Effectiveness of Continuous Glucose Monitoring in Glucose Control and Quality of Life Among Type 1 Diabetic Patients in Madina City: A Cross-Sectional Study.Cureus. 2024 Jul 22;16(7):e65100. doi: 10.7759/cureus.65100. eCollection 2024 Jul. Cureus. 2024. PMID: 39171011 Free PMC article.
-
Continuous glucose monitoring in type 1 diabetes.Endocrine. 2013 Feb;43(1):41-50. doi: 10.1007/s12020-012-9765-1. Epub 2012 Aug 28. Endocrine. 2013. PMID: 22926738 Review.
-
Hypoglycemia in critically ill children.J Diabetes Sci Technol. 2012 Jan 1;6(1):48-57. doi: 10.1177/193229681200600107. J Diabetes Sci Technol. 2012. PMID: 22401322 Free PMC article.
References
-
- Chase HP, Beck R, Tamborlane W, et al. A randomized multi-center trial comparing the GlucoWatch Biographer with standard glucose monitoring in children with type 1 diabetes. Diabetes Care. 2005;28:1101–1106. - PubMed
-
- Fiallo-Scharer R. Eight-point glucose testing versus the continuous glucose monitoring system in evaluation of glycemic control in type 1 diabetes. J Clin Endocrinol Metab. 2005;90:3387–3391. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- U10 HD041906/HD/NICHD NIH HHS/United States
- M01 RR000069/RR/NCRR NIH HHS/United States
- HD041918-01/HD/NICHD NIH HHS/United States
- M01 RR00070-41/RR/NCRR NIH HHS/United States
- HD041908-01/HD/NICHD NIH HHS/United States
- M01 RR000059/RR/NCRR NIH HHS/United States
- U10 HD041919/HD/NICHD NIH HHS/United States
- U01 HD041890/HD/NICHD NIH HHS/United States
- U10 HD041915/HD/NICHD NIH HHS/United States
- U10 HD041908/HD/NICHD NIH HHS/United States
- M01 RR00069/RR/NCRR NIH HHS/United States
- U10 HD041890/HD/NICHD NIH HHS/United States
- HD041890/HD/NICHD NIH HHS/United States
- HD041906-01/HD/NICHD NIH HHS/United States
- M01 RR006022/RR/NCRR NIH HHS/United States
- M01 RR06022/RR/NCRR NIH HHS/United States
- U10 HD041918/HD/NICHD NIH HHS/United States
- HD041915-01/HD/NICHD NIH HHS/United States
- HD041919-01/HD/NICHD NIH HHS/United States
- M01 RR000070/RR/NCRR NIH HHS/United States
- M01 RR00059/RR/NCRR NIH HHS/United States
LinkOut - more resources
Full Text Sources
Medical